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ABSTRACT Plasmids of incompatibility group A/C (IncA/C) are becoming increas-
ingly prevalent within pathogenic Enterobacteriaceae. They are associated with the
dissemination of multiple clinically relevant resistance genes, including blaCMY and
blaNDM. Current typing methods for IncA/C plasmids offer limited resolution. In this
study, we present the complete sequence of a blaNDM-1-positive IncA/C plasmid,
pMS6198A, isolated from a multidrug-resistant uropathogenic Escherichia coli strain.
Hypersaturated transposon mutagenesis, coupled with transposon-directed insertion
site sequencing (TraDIS), was employed to identify conserved genetic elements re-
quired for replication and maintenance of pMS6198A. Our analysis of TraDIS data
identiﬁed roles for the replicon, including repA, a toxin-antitoxin system; two puta-
tive partitioning genes, parAB; and a putative gene, 053. Construction of mini-IncA/C
plasmids and examination of their stability within E. coli conﬁrmed that the region
encompassing 053 contributes to the stable maintenance of IncA/C plasmids. Subse-
quently, the four major maintenance genes (repA, parAB, and 053) were used to con-
struct a new plasmid multilocus sequence typing (PMLST) scheme for IncA/C plas-
mids. Application of this scheme to a database of 82 IncA/C plasmids identiﬁed 11
unique sequence types (STs), with two dominant STs. The majority of blaNDM-
positive plasmids examined (15/17; 88%) fall into ST1, suggesting acquisition and
subsequent expansion of this blaNDM-containing plasmid lineage. The IncA/C PMLST
scheme represents a standardized tool to identify, track, and analyze the dissemina-
tion of important IncA/C plasmid lineages, particularly in the context of epidemio-
logical studies.
KEYWORDS uropathogenic E. coli, IncA/C plasmid, functional genomics, New Delhi
metallo-beta-lactamase, plasmid multilocus sequence typing
IncA/C plasmids are large, low-copy-number, broad-host-range plasmids with varyingcapacities for conjugation (1). These plasmids represent an increasing threat to public
health due to their association with the dissemination of the blaCMY cephalosporinase
genes (2) and more recently the blaNDM metallo-beta-lactamase genes (3–5). The ﬁrst
IncA/C plasmids were isolated from aquatic host species, including the ﬁsh pathogen
Aeromonas salmonicida (6), and pandemic strains of Vibrio cholerae (7, 8). However,
recently, there has been a signiﬁcant increase in the isolation of IncA/C plasmids from
Enterobacteriaceae, including Salmonella (9), Klebsiella pneumoniae (10), and Escherichia
coli (11).
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Plasmids from the IncA/C group were discovered more than 40 years ago and
initially assigned to two separate groups, namely, IncA (RA1) (6) and IncC (12). Subse-
quent investigations into compatibility, exclusion, and phage sensitivity provided
strong evidence for combining these two groups into a single group named IncA/C
(12–14). Molecular analysis of the IncA/C replicon has again split this group into two
distinct types, A/C1 (RA1) and A/C2 (15). The A/C2 type comprises the vast majority of
IncA/C plasmids sequenced to date (1). Plasmid backbone comparisons have informed
the subtyping of IncA/C2 into type 1 and type 2 plasmids (16). The two types differ in
several ways, including two replacement regions (R1 and R2) that lie within rhs and a
large coding sequence (CDS) in transfer region 1, respectively, as well as the presence
or absence of two small segments (i1 and i2) (16). Common features are also found in
relation to resistance gene content, for example, the vast majority of type 1 plasmids
possess the antimicrobial resistance island A (ARI-A) located within rhs and an ISEcp1-
blaCMY insertion within the large CDS in transfer region 1 (16, 17). An additional
resistance island (ARI-B), located upstream of the par locus, is found in both type 1 and
2 plasmids but is not always present.
The IncA/C replicon was ﬁrst deﬁned and characterized using the archetype plasmid
RA1. Thirteen direct repeats (iterons) are located downstream of the repA replication
gene, similar to IncP plasmids (18). Both repA and the iterons are required for IncA/C
replication (19). Similar to other iteron-controlled replicons, there is an imperfect
inverted repeat upstream of repA (18), suggesting autoregulation (20). IncA/C plasmids
also possess a putative toxin-antitoxin (TA) system. The TA genes are strongly tran-
scribed, suggesting the system is functionally active in the postsegregation killing of
plasmid-free progeny (21). Moreover, attempts to construct deletion mutants of the
antitoxin component proved to be lethal to the cell (22).
Partitioning systems are one of the most important factors that contribute to the
stable inheritance of large, low-copy-number plasmids (23). Partitioning typically in-
volves three components: a cis-acting DNA binding site (centromere; parS), a centro-
mere binding protein (ParB), and an NTPase (ParA) (24). Together, they facilitate the
correct positioning of plasmid molecules during cell division to increase plasmid
retention (25). Partitioning systems are classiﬁed into different groups based on the
characteristics of the NTPase (24). The IncA/C ParA protein contains a Walker-type
ATPase, indicating IncA/C plasmids possess a type I partitioning system (1, 25). This
ParA protein has similarity to ParA of IncP plasmids, while IncA/C ParB contains both
ParB and KorB domains (1). These genes are transcribed at low levels, similar to repA
(21). Another putative partitioning gene, stbA, is found in a separate genetic location.
StbA has similarity to the ParM partitioning protein from the IncFII plasmid NR1 (1). In
addition to these elements, IncA/C plasmids carry a number of other genes putatively
involved in replication, including kfrA and ter (1). However, the functions of these genes
have not been experimentally determined.
Transposon-directed insertion site sequencing (TraDIS), along with other, similar
techniques, including Tn-seq (26), INseq (27), and HITS (28), is a high-throughput
whole-genome screening method used to perform bacterial functional genomic anal-
yses (29, 30). A typical TraDIS experiment examines a highly saturated transposon
mutant library under a condition of interest, with pre- and postselection libraries
subjected to deep sequencing to simultaneously identify all of the transposon insertion
sites. After selection, the lack of insertions within a gene is used to determine the
importance of that gene for survival under the condition tested. The technique has
been applied to identify genes that enable the maintenance and transmission of the
IncI1 plasmid pESBL (31) and the essential genes of the IncF plasmid pEC958 (32). Here,
we employed TraDIS to identify genetic elements involved in the replication and
maintenance of the IncA/C plasmid group. These experimentally validated elements
provided a framework for development of a novel plasmid multilocus sequence typing
(PMLST) scheme for tracking this important plasmid group.
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RESULTS
Genomic analysis of the carbapenem-resistant E. coli strain MS6198. MS6198 is
a carbapenem-resistant uropathogenic Escherichia coli (UPEC) strain. MS6198 is also
nonsusceptible to multiple other antibiotics, including beta-lactams, nalidixic acid,
ciproﬂoxacin, gentamicin, kanamycin, sulfamethoxazole, trimethoprim, tetracycline,
and tobramycin (see Data Set S1 in the supplemental material). The complete genome
of MS6198 was determined and shown to consist of a circular chromosome comprising
5,176,750 base pairs (51.59% G-C content). In silico typing assigned MS6198 to se-
quence type 648 (ST648), which has been associated with a number of disease
outbreaks in Asia and Europe (33–35). MS6198 contained a number of UPEC virulence
factors, including genes encoding type 1 ﬁmbriae, Ag43, capsule, and several iron
acquisition systems. A list of known UPEC virulence genes found in MS6198 is shown
in Data Set S2 in the supplemental material. In addition, MS6198 contained 4 circular
plasmids, pMS6198A (IncA/C type; 137,565 bp), pMS6198B (IncFII type; 128,428 bp),
pMS6198C (untypeable; 98,242 bp), and pMS6198D (IncI1 type; 50,899 bp). Methylome
analysis of MS6198 identiﬁed three distinct DNA recognition motifs, indicating the
presence of at least three active adenine methyltransferase enzymes (see Data Set S3
in the supplemental material).
Characterization of an IncA/C multidrug resistance plasmid harboring the
blaNDM-1 carbapenemase gene. We focused our study on characterization of the
blaNDM-1-positive IncA/C plasmid pMS6198A. Plasmid pMS6198A belongs to type 1 of
the IncA/C2 group and contains 172 CDSs classiﬁed into seven functional groups (Fig.
1). The plasmid contains the typical IncA/C replicon and additional putative mainte-
nance genes, including parAB, parM, kfrA, and a putative TA system. Similarity searches
of public sequence databases indicated that pMS6198A contains 19 conjugation genes,
including the master regulators acaDC (22). In addition to a typical ISEcp1-blaCMY-6
insertion within transfer region 1, ﬁve resistance genes are located within ARI-A—
aacA4, rmtC, blaNDM-1, bleMBL, and sul1—along with a truncated qacEΔ1 gene. Plasmid
pMS6198A contains 92 CDSs that have no assigned annotation.
Sequence comparison with other IncA/C plasmids showed that pMS6198A displayed
99% conservation over its entire sequence with two other blaNDM-1-positive IncA/C
plasmids: pKP1-NDM1 (KF992018) from Australia and pNDM10469 (JN861072) from
FIG 1 Genetic map of pMS6198A. The outermost rings are CDSs on forward and reverse strands. The
CDSs are color coded as follows: replication, red; maintenance, yellow; DNA modiﬁcation, green;
conjugative, blue; mobile element, light pink; antimicrobial resistance, dark pink. The inner rings are GC
plot (outer) and GC skew (inner).
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Canada. The genetic structure of blaNDM-1 in pMS6198A is highly similar to those of
eight other IncA/C plasmids (see Fig. S1 in the supplemental material). A full comple-
ment of transfer genes, as deﬁned previously (1), were present in pMS6198A. Accord-
ingly, pMS6198A was transferable by conjugation in static liquid culture at 37°C to the
recipient strain E. coli J53 at a frequency of 103 transconjugants per donor. Transfer of
pMS6198A to J53 was conﬁrmed by PCR ampliﬁcation of the IncA/C replicon. Antibiotic
resistance proﬁling of the transconjugant strain (MS6614 [see Data Set S1 in the
supplemental material]) showed that pMS6198A was capable of conferring resistance
to multiple antibiotics, including cefotaxime-clavulanic acid, ceftazidime-clavulanic
acid, piperacillin-tazobactam, amoxicillin-clavulanic acid, cefoxitin, cefpodoxime, ceftri-
axone, cephalothin, ampicillin, gentamicin, kanamycin, imipenem, meropenem, ertap-
enem, and tobramycin. Puriﬁcation of pMS6198A from MS6614 and electrotransforma-
tion into E. coli TOP10 were performed, with subsequent analysis of the transformed
TOP10 strain by PCR, conjugation, and antibiotic resistance proﬁling indicating the
integrity of the plasmid was maintained (see Data Set S1 in the supplemental material).
Thus, all subsequent analysis of pMS6198A was performed using plasmids puriﬁed from
MS6614.
Identiﬁcation of genes required for pMS6198A maintenance and replication.
To identify the genes required for the maintenance and replication of pMS6198A in E.
coli, we employed in vitro mutagenesis in combination with TraDIS as shown in Fig. 2.
First, in vitro mini-Tn5 mutagenesis of pMS6198A was carried out to create a highly
saturated mutant plasmid DNA library. This library was transformed into E. coli TOP10
by electroporation and subsequently grown in the presence of chloramphenicol to
select for pMS6198A::mini-Tn5-containing transformants. This process was performed
in duplicate, resulting in two saturated libraries, each of which contained approximately
10,000 transformants. Puriﬁed plasmid DNA was extracted from both libraries and
analyzed by TraDIS. Examination by inverse PCR of a subset of individual Tn5 mutant
colonies was performed to investigate the randomness of insertion and the number of
insertions per plasmid molecule. The majority of mutants examined (17/18; 94%)
contained a single insertion, each at a different location on the plasmid (see Fig. S2 in
the supplemental material).
TraDIS identiﬁed a total of 10,178 unique insertion sites in pMS6198A from the two
libraries, which was equivalent to an average of one insertion site every 13.52 bp.
Correlation tests of insertion sites per gene for each library showed high reproducibility
for the TraDIS sequencing method (R2  0.99) (see Fig. S3 in the supplemental
material). The relative abundance of reads mapped to mini-Tn5 insertion sites within
each gene (expressed in reads per kilobase per million [RPKM]) was calculated (Fig. 3A;
FIG 2 Overview of pMS6198A in vitro mutagenesis and TraDIS analysis. (1) Tn5::Cm transposons were
inserted into pMS6198A. (2) The mutagenized plasmid mixture was transformed into E. coli TOP10 by
electroporation, and mutant plasmids were selected by growth in the presence of chloramphenicol. (3) All
mutant chloramphenicol-resistant colonies were counted, pooled, and stored at 80°C. Two replicate
libraries were generated by this method. (4) Genomic DNA was extracted from each library for TraDIS
analysis.
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see Data Set S4 in the supplemental material). This enabled us to identify genes
required for the maintenance and replication of pMS6198A, as plasmids containing
mutations in such genes would be lost and thus underrepresented in the libraries,
reﬂected as a low RPKM value.
The repA gene is known to be required for IncA/C plasmid replication (19), and we
observed a relative abundance of mini-Tn5 insertions in repA (418 RPKM) (Fig. 3Ci)
signiﬁcantly lower than the average insertion abundance for all pMS6198A genes (7,222
RPKM). Therefore, we used 418 RPKM as a biological threshold for genes required for
replication and maintenance of pMS6198A. Six additional genes were identiﬁed with
insertion abundances lower than this threshold: 022, parA, parB, 053, tnpA, and rmtC
(Fig. 3B).
The putative TA system of IncA/C plasmids belongs to the tad-ata-like family found
in a range of different genetic elements, including ICE SXT, Enterobacteria phage N15,
a genomic island of E. coli EDL933, and the plasmid pAMI2 (36). The 022 gene (here
referred to as ata, for antitoxin of addiction system) lies immediately adjacent to the
023 gene (referred to as tad, for toxin of addiction system) (Fig. 3Cii). Both tad and ata
are 100% conserved in all fully sequenced IncA/C2 plasmids but absent from IncA/C1
plasmids. Tad is a member of the Gp49 family proteins (Pfam identiﬁer PF05973), which
is comprised of known toxins. In the phage N15, Gp49 is controlled by the adjacently
encoded Gp48 protein (UniProt accession no. O64356), which contains a helix-turn-
helix (HTH) DNA binding domain (36). Analysis of the Ata amino acid sequence showed
it is 24% identical and 50% similar to that of Gp48 (71% coverage) and possesses an
HTH domain (Pfam identiﬁer PF13744), suggestive of a DNA binding function. Our
TraDIS data showed that mutation of ata is strongly underrepresented, while mutation
of tad is tolerated. Taken together, our data suggest that ata and tad encode an active
TA system, in which Ata is the antitoxin.
Three adjacent genes, parA (051), parB (052), and 053, were also identiﬁed in our
TraDIS analysis (Fig. 3Ciii). The three genes are conserved in all fully sequenced IncA/C
plasmids. ParA belongs to an ATPase family (Pfam identiﬁer PF13614), while ParB
contains both ParB (Pfam identiﬁer PF02195) and KorB (Pfam identiﬁer PF08535)
domains. Based on bioinformatics analysis, parA and parB are homologous to IncP
partitioning genes. The third gene in the locus (053) encodes a hypothetical protein of
90 amino acids (aa) containing a winged HTH domain (Pfam identiﬁer PF09904),
suggestive of a DNA binding function. Additionally, 053 is present at the same genetic
location (after parB) in all IncA/C plasmids.
FIG 3 Essential gene TraDIS read data. (A) RPKM for each gene listed on the x axis. The red lines indicate genes
below the 418-RPKM threshold; the blue lines indicate genes present in all 82 IncA/C plasmids and above the
418-RPKM threshold; the black lines indicate all other genes above the 418-RPKM threshold. (B) Genes with 418
RPKM. The red lines indicate positions on the graph and pMS6198A sequence. (C) Enlarged view of the genetic
environment for each gene in panel B. The graphs show the number of transposon reads mapped to each position.
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Two other genes, tnpA and rmtC, were identiﬁed in our TraDIS screen (Fig. 3Civ and
v). The tnpA gene encodes a transposase from the insertion sequence ISEcp1 (37), while
rmtC encodes a 16S ribosomal methyltransferase (UniProt entry Q33DX5) that confers
resistance to many aminoglycoside antibiotics. These two genes occupy regions of
pMS6198A with the lowest G-C content (see Fig. S4 in the supplemental material) that
may be associated with an insertion bias (38). Furthermore, the genes are not con-
served among completely sequenced IncA/C plasmids, being present in only 50% and
11%, respectively. Based on these data, they are unlikely to be involved in the
maintenance and replication of pMS6198A.
The par locus of IncA/C plasmids, of which 053 is a crucial component, con-
tributes to stability. TraDIS analysis identiﬁed two putative partitioning genes (parA
and parB) and a region containing an open reading frame (ORF) immediately down-
stream of parB (053) as required for plasmid maintenance. Bioinformatics analysis
revealed that the structural organization of parA-parB-053 is completely conserved in all
sequenced IncA/C plasmids examined in this study. This led us to hypothesize that the
partitioning system in IncA/C is comprised of three components that are all required for
plasmid stability in E. coli. To provide evidence to support our hypothesis, we con-
structed pMS6198A-derived mini-A/C plasmids containing different versions of the
partitioning locus and examined their stability in E. coli strain MG1655. The mini-A/C
plasmid contained the IncA/C replicon, as previously described (1, 18, 19). A selectable
marker (cat cassette, conferring chloramphenicol resistance) was included, along with
two transcriptional terminators to prevent transcriptional read-through from the cas-
sette. Two variations of the partitioning locus were incorporated into this mini-A/C
plasmid, generating pMAC2 (parAB) and pMAC3 (parAB plus 053) (Fig. 4A).
The stability of pMS6198A was initially examined by growth in the absence of
selection for three serial passages, each incorporating 10 generations. After 30 gener-
ations, no plasmid loss was observable (see Fig. S5 in the supplemental material),
highlighting the high stability of the parent plasmid. The same experiment was used to
assess the stability of pMAC2 and pMAC3. This showed that pMAC2 was less stable than
pMAC3: even at time zero, only 50% of cells retained pMAC2, and by 30 generations,
this had dropped to 2% (see Fig. S5 in the supplemental material). In contrast, pMAC3
started at 100% and was reduced to 64% after 30 generations (see Fig. S5 in the
supplemental material).
FIG 4 Contribution of the partitioning locus to IncA/C stability. (A) Plasmid map of mini-IncA/C constructs pMAC2 and pMAC3.
Compared to plasmid pMAC2, plasmid pMAC3 contains an additional 420-bp fragment downstream of parB. (B) Time course
plasmid stability assay in broth culture. At each time point, cultures were serially diluted and grown on LB agar with or without
Cm to determine the percentage of plasmid-positive cells relative to time zero. Starting cultures consisted of 50% plasmid-
positive plus 50% plasmid-free cells. The assays were performed in triplicate. The data points are means standard deviations.
*, P  0.005; **, P  0.0001.
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The difference in plasmid stabilities observed between the starting populations of
pMAC2 and pMAC3 (time zero) was addressed by mixing cells harboring pMAC3 in a 1:1
ratio with plasmid-free cells, thus mimicking the starting population of cells harboring
pMAC2. Analyses using this equivalent starting population resulted in plasmid stability
proﬁles very similar to those observed in the single-strain experiment, with pMAC2-
harboring cells reduced to 5% after 30 generations compared to signiﬁcantly higher
(57%) retention of pMAC3 (Fig. 4B).
The TraDIS-identiﬁed maintenance genes are conserved in all IncA/C plasmids.
Plasmid multilocus sequence typing was originally developed for the typing of large
collections of plasmids using a set of conserved genes (39). In the context of IncA/C
plasmid typing, our TraDIS data have provided a deﬁned subset of genes with essential
plasmid maintenance functions that could be used in the development of a PMLST
scheme. To provide a framework for this analysis, a collection of 82 complete IncA/C
plasmid sequences available in the GenBank database were examined for overall
sequence conservation (see Data Set S5 in the supplemental material). A total of 28
genes were completely conserved within this collection, which included the four genes
identiﬁed by TraDIS (repA, parA, parB, and 053) (Table 1). The concatenated sequences
of all 28 fully conserved genes from each plasmid were used to build a maximum-
likelihood tree (Fig. 5, left). Interestingly, this analysis identiﬁed multiple previously
deﬁned hybrid plasmid groups, including pYR1 and p39R861-4, and also differentiated
between type 1 and 2 A/C2 plasmids (1, 16, 40), with type 1 plasmids also separated into
three distinct groups. Using this as a baseline, the discriminatory power of repA, parA,
parB, and 053 was examined by using the concatenated sequences of the four genes
from each plasmid to build a maximum-likelihood tree (Fig. 5, right). The overall
topology of the tree is similar to our analysis of IncA/C plasmids using all 28 conserved
genes, including a split between IncA/C1 (group 5) and IncA/C2 (groups 1 to 4). The
IncA/C2 lineage was further split into four distinct groups; groups 1 and 2 comprised
type 1 plasmids, and group 3 included both type 1 and type 2 plasmids, while group
TABLE 1 Conserved genes in the IncA/C plasmid database
Gene Product Base rangea Length (bp)a
repA Replication protein RepA 1–1101 1,101
002 Hypothetical protein c(2138–2572)b 1,116
004 Hypothetical protein 3973–4581 609
005 Hypothetical protein 4586–5107 522
007 Hypothetical protein 5728–6201 474
008 Hypothetical protein 6191–6505 315
009 Hypothetical protein 6510–7364 855
010 Signal peptide peptidase 7364–8323 960
011 Putative protein-disulﬁde isomerase 8339–9199 861
015 Hypothetical protein 10521–11039 519
017 Hypothetical protein 11256–12113 858
050 Hypothetical protein 28936–29247 312
parA Partitioning protein ParA 29421–30206 786
parB Partitioning protein ParB 30210–31391 1,182
053 Putative DNA binding protein 31440–31712 273
054 Putative DNA methyltransferase c(31765-32400) 636
055 Hypothetical protein c(32492-32635) 144
056 Hypothetical protein 32962–33339 378
058 Hypothetical protein 33588–34262 675
059 Hypothetical protein 34255–34761 507
xerD Putative intergrase XerD 118619–119629 1,011
kfrA Putative DNA binding protein KfrA 122338–123378 1,041
traH Putative pilus assembly protein TraH 126329–127762 1,434
167 Hypothetical protein c(131427–131789) 363
169 Putative lytic transglycosylase 132777–133310 534
acr2 H-NS histone family protein c(134537-134956) 273
173 Hypothetical protein c(134958-135251) 294
mobI Plasmid transfer protein MobI 136927–137289 363
aAs in pMS6198A.
bc denotes CDS on reverse strand.
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4 represented the hybrid plasmid pYR1. Although the resolution of the 28 conserved
genes separated hybrid plasmid p39R861-4 and both type 1 and type 2 plasmids, their
similarity in the sequences of repA-parA-parB-053 clustered the plasmids together in
group 3. Furthermore, the preservation of groups 1, 2, 4, and 5 between the two
analyses highlights them as distinct plasmid lineages. Taken together, the analysis
demonstrates that the sequences of the four essential genes identiﬁed by TraDIS are
sufﬁcient to capture the phylogenetic relatedness of IncA/C plasmids and could be
used for molecular typing.
Development of an IncA/C PMLST scheme. As the repA, parA, parB, and 053 genes
could distinguish different groups of IncA/C plasmids, we used these biologically
FIG 5 TraDIS-identiﬁed essential genes describe IncA/C phylogeny. Shown is a comparison of IncA/C phylogenies using 28 conserved genes (left) and 4 required
genes (right). The brown and green boxes show IncA/C types, and the red and blue boxes show TraDIS gene groupings, as indicated. TraDIS gene groups were
assigned based on 99% sequence similarity.
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validated genes to develop a PMLST scheme for IncA/C plasmids. Ampliﬁcation and
sequencing primers were designed to target conserved regions within each essential
gene (Table 2). PCR and Sanger sequencing using these primers were performed on
pMS6198A to validate the methodology. Using the sequences obtained in silico from 82
IncA/C plasmids, different alleles for repA (n  5), parA (n  6), parB (n  7), and 053
(n  3) were identiﬁed, which together form 11 STs, as shown in Fig. 6 (see Data Set
S6 in the supplemental material). The minimum spanning tree comprises two single-
tons, ST10 (pYR1; IncA/C2) and ST11 (RA1; IncA/C1), with the remaining nine STs linked
together as single-locus variants (SLVs) or double-locus variants (DLVs). ST3 is the
largest group and includes 53 plasmids. ST3 connects to ST4, ST5, ST6, ST7, ST8, and ST9
as SLVs, forming a clonal complex with ST3 as the founder (ST3 clonal complex
[ST3CC]). ST3 links with ST2 as a DLV, and ST2 connects to ST1 as an SLV. ST1 is the
second largest group and comprises 20 plasmids. ST1 and ST3 together account for
89% of the total IncA/C plasmids investigated.
To provide higher-resolution typing applicable to next-generation sequencing data,
a core gene PMLST (cgPMLST) scheme was also constructed by extending the 4-gene
PMLST to 28 conserved genes (see Data Set S7 in the supplemental material). The four
loci shared between the two schemes allow backward compatibility from cgPMLST to
PMLST. Thus, cgPMLST is capable of subtyping 11 STs into 35 subgroups, including 4
TABLE 2 Primers for IncA/C plasmid multilocus sequence typing
Primer Sequence (5=–3=) Primer information
Amplicon
size (bp)a
repA-F AAGAGAACCAAAGACAAAGAC Amplify repA 982
repA-R GCTGCTTACGCTTGTTGGA
parA-F AAAAGTAATCAGCTTCGCCA Amplify parA 780
parA-R TAGCCCACCTTCTCTAATAG
parB-F TGTCCGAACTTGCTAAAGC Amplify parB 1,128
parB-R CTGACACAGGCACATGAA
053-F AGATCTCACAGGACATGAA Amplify 053 250
053-R TTCAAGAACGAAGACCTGT
repA-Seq1 TGGAGTTCGTACAGAGTGA Sequence 5= region of repA fragment NA
repA-Seq2 GCTCCAGCTTCTTCCCGAT Sequence 3= region of repA fragment NA
parB-Seq1 CACACAGTCAGGTAGCTT Sequence 5= region of parB fragment NA
parB-Seq2 AAGCTACCTGACTGTGTG Sequence central region of parB fragment NA
parB-Seq3 GATGCTCTTCCTCCTCTG Sequence 3= region of parB fragment NA
aNA, not available.
FIG 6 Minimal spanning tree of IncA/C PMLST. The branch lengths indicate the numbers of allele
differences between STs. The pie charts for each ST indicate the species of isolation. The gray rectangle
encompasses STs belonging to the ST3 clonal complex. A. hydrophila, Aeromonas hydrophila; C. freundii,
Citrobacter freundii; E. aerogenes, Enterobacter aerogenes; E. cloacae, Enterobacter cloacae; K. oxytoca,
Klebsiella oxytoca; P. damselae, Photobacterium damselae; P. stuartii, Providencia stuartii; S. marcescens,
Serratia marcescens; V. alginolyticus, Vibrio alginolyticus; Y. pestis, Yersinia pestis; Y. ruckeri, Yersinia ruckeri.
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subgroups for ST1 (ST1.1 to ST1.4), 22 subgroups for ST3 (ST3.1 to ST3.22), and 1
subgroup for each of the remaining STs (see Data Set S7 and Fig. S6 in the supple-
mental material).
IncA/C PMLST highlights a lineage of blaNDM-harboring plasmids. To determine
if the distribution of antibiotic resistance genes among IncA/C plasmids is associated
with STs, the resistance gene content of each plasmid was overlaid with the PMLST
phylogenetic scheme (Fig. 7). Examination of the resistance gene proﬁles highlighted
distinct patterns between ST1 and ST3CC. ST1 predominantly harbors blaCMY-6, while
FIG 7 Phylogeny and resistance gene proﬁles of IncA/C plasmids. The tree was built using sequences derived from the PMLST analysis. Plasmids that contain
a blaNDM structure similar to that present in pMS6198A (see Fig. S1 in the supplemental material) are indicated by asterisks. The full list of resistance genes is
shown in Data Set S8 in the supplemental material in the same order as in the ﬁgure.
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ST3CC plasmids mainly possess the blaCMY-2 variant (Fig. 7). ST3CC also exhibits a higher
prevalence of tetracycline and streptomycin resistance genes. ST1 is strongly associated
with the carriage of blaNDM (15/20 plasmids; 75%), while only two plasmids outside ST1
carry blaNDM (one each from ST3 and ST6). Comparison of the blaNDM genetic location
has shown multiple genetic organizations (41–46). Within our database, we observed a
total of seven distinct blaNDM structures (see Fig. S1 in the supplemental material). Six
of them are found in individual plasmids (pNDM-SAL, ST1; pNDM-1_Dok01, ST1;
pEC2-NDM-3, ST1; pNDM15-1078, ST1; pRH-1238, ST3; and pMR0211, ST6), and one has
been observed within ARI-A of nine plasmids (45, 47). All nine plasmids belong to ST1,
subgroups ST1.2 and ST1.4 (see Fig. S6 in the supplemental material). Overall, non-ST1
blaNDM structures are distinct from all others, while the presence of similar structures in
9/15 ST1 plasmids suggests the successful dissemination and diversiﬁcation of the
plasmid lineage.
DISCUSSION
Carbapenem-resistant Enterobacteriaceae have been recognized as an urgent threat
to human health (48). Infections caused by these bacteria are often resistant to almost
all clinically available antibiotics and are frequently associated with poor health out-
comes. New Delhi metallo--lactamase is a recently emerged carbapenemase ﬁrst
described in 2009 (49). Since then, several IncA/C plasmids carrying the blaNDM-1 gene
(4, 41, 47, 50–52), and recently blaNDM-3 (45), have been reported. Plasmids of incom-
patibility group A/C have been known for more than 40 years, but they have only
recently gained increased interest due in part to their emergence as the major plasmid
type carrying the cephalosporinase gene blaCMY (2). However, the broad-host range
characteristic of IncA/C plasmids and their roles in the dissemination of multiple
antibiotic resistance genes, including blaCMY and blaNDM, are underappreciated. Here,
we have used a validated set of essential genes to develop a high-resolution typing
scheme to monitor the spread and transmission of IncA/C plasmids.
Previous studies on the replicon of RA1, the prototypical IncA/C plasmid, showed
that IncA/C plasmid replication is mediated by the autoregulated repA gene and an
iteron upstream of a DnaA box (19). Indeed, our mutagenesis analysis conﬁrmed a
requirement for repA and its adjacent iteron region in pMS6198A (Fig. 3Ci). This
validated our method to identify required genetic components and also served as a
reference point for identiﬁcation of six other genes, namely, ata, parA, parB, 053, tnpA,
and rmtC.
The addiction system of IncA/C plasmids has been the subject of various studies, but
its contribution to IncA/C plasmid stability has not been fully established. Recent
transcriptome analysis of pAR060302 showed that the system is strongly transcribed
(21). Furthermore, multiple attempts to mutate ata were ultimately unsuccessful (22).
Our TraDIS data conﬁrmed that atamutants were highly underrepresented. This is likely
a result of uncontrolled toxin expression leading to cell death and demonstrates that
the system is active in pMS6198A. The activity of the system may contribute to the
variation in stability between the parent plasmid, pMS6198A, and pMAC3 (see Fig. S5
in the supplemental material). Moreover, it is possible that additional stability elements
may be present on pMS6198A that exert subtle effects undetected by our stringent
TraDIS threshold.
A putative partitioning locus is present in all IncA/C plasmids. It has been noted that
the parA and parB genes share similarity to IncP plasmid partitioning and regulatory
elements (1). Our TraDIS data strongly support a role for these genes in the mainte-
nance and stability of IncA/C plasmids. Additionally, we identiﬁed the adjacent ORF,
053, as a novel element of the locus that has no IncP homolog. We showed that parAB
alone were not sufﬁcient for maintenance (Fig. 4, pMAC2) and that plasmid stability
improved markedly with the addition of a 420-bp fragment containing ORF 053 (Fig. 4,
pMAC3). Our results invoke at least two hypotheses: that a parS cis-acting centromere-
like site of the ParAB partitioning system is present within this region or that 053
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encodes a novel partitioning protein. Further work is required to elucidate the mech-
anisms by which this 420-bp region contributes to plasmid stability.
Plasmid pMS6198A carries a number of other genes with putative replication and
maintenance functions, including kfrA (161) and stbA (174). However, they were not
identiﬁed by TraDIS analysis (see Data Set S4 in the supplemental material), suggesting
they are not critical to pMS6198A maintenance in E. coli. Conversely, tnpA and rmtC
have functions unrelated to plasmid stability yet were identiﬁed. Both genes have low
GC contents (34% and 41%, respectively, compared to an average of 52%) across the
entire pMS6198A sequence. This is consistent with an overall increased mini-Tn5
insertion frequency in high- versus low-GC regions of pMS6198A (see Fig. S4 in the
supplemental material). Thus, the identiﬁcation of these genes may be the result of
insertion bias of the Tn5 transposon in the in vitro mutagenesis reaction (38).
Deciphering phylogenetic relationships among plasmids can be challenging due to
their mosaic nature. However, within one plasmid incompatibility group, it is expected
that replication and maintenance machineries required for its biology should be
conserved. This notion has been successfully applied to select genes for multilocus
sequence typing schemes of plasmids from many Inc groups, including IncI1 (39),
IncHI1 (53), IncHI2 (54), and IncN (55). Here, we propose a new PMLST scheme for
IncA/C plasmids based on an experimentally validated set of essential genes. The loci
selected for our PMLST scheme were based on the required genes identiﬁed by TraDIS
analysis and supported by their presence in all IncA/C plasmids investigated. The
scheme identiﬁed 11 sequence types, demonstrating higher resolution than current
typing methods. We suggest that our PMLST scheme could be used to monitor
dissemination and diversiﬁcation patterns of IncA/C plasmids.
Of the 11 IncA/C sequence types, the majority of plasmids belong to two main types:
ST1 and ST3. ST3 is the largest group, comprising 53 plasmids that form a clonal
complex (ST3CC) with plasmids from ST4, ST5, ST6, ST7, ST8, and ST9 (Fig. 6). The ST3CC
plasmids were isolated from 1969 to 2015 in 19 countries and 16 species (Fig. 6; see
Data Set S5 and Fig. S7 in the supplemental material), highlighting their wide geo-
graphical distribution and broad host range characteristics. Interestingly, the IncA/C2
type 1 plasmids within ST3CC showed strong association with blaCMY (23/31; 74%). As
highlighted previously, the high frequency of blaCMY-positive IncA/C plasmids isolated
from Salmonella enterica in the United States is an indication of sampling bias within
the data set (1).
ST1 is the second-largest group in our data set, with 20 plasmids. The most striking
feature of ST1 is the strong association with the carriage of blaNDM, with the majority
of ST1 plasmids isolated from E. coli and K. pneumoniae. The clinical relevance of these
species and carbapenem resistance has likely contributed to a sampling bias of ST1
plasmids. Nevertheless, it is tempting to hypothesize that ST1 is a newly emerged
lineage of IncA/C plasmids, with carbapenem resistance enhancing its selection and
dissemination. Further work is needed to test this hypothesis; however, the presence of
a common blaNDM structure in speciﬁc ST1 plasmid subgroups is supportive of the
tenet. The observation of most concern here is the identiﬁcation of ST1 in nine
countries spanning four continents (see Data Set S5 and Fig. S7B in the supplemental
material), highlighting the urgent need for surveillance and control of this extensively
drug-resistant plasmid lineage.
More in-depth investigations within each ST may provide a better framework for
analyzing the evolution of IncA/C plasmids. Inspired by the development of core
genome MLST schemes (56), we have also constructed a cgPMLST scheme for IncA/C
plasmids using the 28 conserved genes identiﬁed in our database (see Fig. S6 and Data
Set S7 in the supplemental material). IncA/C cgPMLST is intended as a subtyping
scheme complementary to PMLST to increase the discriminatory power suitable for
plasmid epidemiology studies. The discriminatory power, measured by Hunter’s index
(57), of our IncA/C PMLST is 0.53 and is increased to 0.90 for cgPMLST. Other methods,
such as that proposed by Harmer and Hall (58), could also be used in conjunction with
PMLST to subtype IncA/C plasmids.
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While sequence data from next-generation sequencing platforms, especially those
from Paciﬁc Biosciences (PacBio), would provide full plasmid backbone sequences for
in-depth epidemiology and high-resolution phylogeny analysis, such technologies
remain out of reach for many laboratories in developing countries, where surveillance
and control measures are most needed. Our PMLST scheme provides a robust method
based on PCR and Sanger sequencing for the identiﬁcation of major lineages of IncA/C
plasmids. These major lineages can then be subtyped using cgPMLST when whole-
plasmid sequence data are available. Like other MLST-based schemes, both of our
schemes are compatible with freely available tools, such as SRST2 (59) and pMLST (60),
for in silico determination of plasmid STs, enabling the use of typing data across
different settings. Our PMLST and cgPMLST schemes are also available on the public
databases for molecular typing and microbial genome diversity (PubMLST) (79).
MATERIALS AND METHODS
Bacterial strains and growth conditions. E. coli MS6198 was isolated from the urine of a patient
with a urinary tract infection in Haryana, India, in 2010 (61). The E. coli strain J53 was provided by G.
Jacoby (62). The strains were routinely cultured at 37°C under orbital shaking (250 rpm), in liquid or on
solid lysogeny broth (LB) medium, supplemented with appropriate antibiotics. The following concen-
trations were typically used: ampicillin, 100 g/ml; sodium azide, 100 g/ml; meropenem, 1 g/ml; and
chloramphenicol, 30 g/ml. Electrocompetent cells were prepared, and transformations were performed
as described previously (29). All the strains were stored in 15% glycerol at 80°C.
DNA puriﬁcation and analysis. The PureLink HiPure Midiprep plasmid DNA puriﬁcation kit (Invit-
rogen) was used to purify pMS6198A, while vector plasmids (10 kb) were puriﬁed with the QIAprep
Spin Miniprep kit (Qiagen). Genomic DNA was obtained with MoBio’s Ultraclean microbial DNA isolation
kit. DNA concentrations were quantiﬁed using a NanoDrop 2000 (Thermo Scientiﬁc) and/or Qubit 2.0 (Life
Technologies) ﬂuorometer.
PCR and sequencing. The presence of plasmids was determined by PCR- based replicon typing (63,
64); blaNDM was identiﬁed with primers 5=-GGTTTGGCGATCTGGTTTTC-3= and 5=-CGGAATGGCTCATCACG
ATC-3= as previously described (65), using One Taq polymerase (New England BioLabs). All restriction
enzymes, T4 ligase, and Antarctic phosphatase were purchased from New England BioLabs. All capillary
sequencing reactions were prepared using BigDye Terminator mix and sequenced by the Australian
Equine Genetics Research Centre (AEGRC). A full list of primers used in this study is shown in Data Set
S9 in the supplemental material.
PMLST PCR and sequencing protocol. Ampliﬁcation of the four loci used in PMLST was performed
with Kapa HiFi DNA polymerase (Kapa Biosystems) using primers listed in Table 2 with the following
cycling program: 95°C for 3 min; 25 cycles of 98°C for 20 s, 60°C for 15 s, and 72°C for 30 s; and a ﬁnal
extension of 72°C for 3 min. Each amplicon was then puriﬁed using the QIAgen PCR puriﬁcation kit and
sequenced using BigDye Terminator v3.1 cycle sequencing (Life Technology) with the appropriate
sequencing primers listed in Table 2.
Disc diffusion and mating assays. The disc diffusion assay was performed and interpreted accord-
ing to the Clinical and Laboratory Standards Institute guidelines (2014). Antimicrobial discs were
obtained from Becton Dickinson. For mating assays, the sodium azide-resistant E. coli strain J53 (62) was
used as the recipient in all mating assays. Donor and recipient strains were grown to an optical density
at 600 nm (OD600) equal to 2.0. The cells were then mixed at a ratio of 1:2 (donors to recipients) in LB
and incubated at 37°C for 2 h under static conditions. Total CFU of donors, recipients, and transconju-
gants were enumerated on LB agar plates with appropriate antibiotic selection (ampicillin for donors and
sodium azide for recipients), and the conjugation frequency was calculated as the number of transcon-
jugants per donor.
Plasmid stability assays. Time course stability assays were performed essentially as previously
described (66). Population counts were achieved by 10-fold serial dilutions and 5-l drop test on LB agar
with or without selection. For solid-medium stability assays, strains were grown overnight on LB agar
supplemented with antibiotics, and then single colonies were suspended in 0.9% NaCl. Population
counts were achieved by 10-fold serial dilutions and 5-l drop tests on LB agar with or without selection.
In vitro transposon mutagenesis. A custom mini-Tn5 transposon containing a chloramphenicol
resistance cassette (Tn5-Cm) was generated as previously described (30). An in vitro plasmid mutant
library was created by incubating 200 ng of pMS6198A DNA and equimolar Tn5-Cm DNA (1.588 ng) with
1 l of Tn5 transposase (1 U/l) from an EZ-Tn5 R6Kori/KAN-2 insertion kit (Epicentre) at 37°C for
2 h. The reaction was stopped by adding 1 l 1% SDS and heating at 70°C for 10 min. The mutant plasmid
library (1 l) was transformed into 50 l of E. coli TOP10 electrocompetent cells. Cells carrying mutant
plasmids were selected by plating on LB agar supplemented with chloramphenicol. Mutants were pooled
by scraping colonies off agar plates into LB. After addition of glycerol to a ﬁnal concentration of 15%, the
mutant library was stored at 80°C.
Inverse-PCR method. Puriﬁed DNA from individual mutants was digested with BanII for 2 h at 37°C
and heat inactivated at 65°C for 20 min. This mixture was ligated with T4 DNA ligase overnight at 16°C.
This ligation mixture was used as the template for PCR using OneTaq and cat-speciﬁc primers 3748 and
3950, with thermocycling: 94°C for 1 min; 30 cycles of 94°C for 30 s, 62°C for 30 s, and 68°C for 3.5 min;
and a ﬁnal extension time of 5 min.
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Transposon-directed insertion site sequencing. Illumina library preparation was performed using
a Nextera DNA Sample Prep kit (Illumina) following the manufacturer’s instructions with modiﬁcations for
TraDIS. Brieﬂy, genomic DNA was fragmented and tagged with adapter sequence via one enzymatic
reaction (tagmentation). Following tagmentation, the DNA was puriﬁed using the Zymo DNA Clean and
Concentrator kit (Zymo Research). The PCR enrichment step was run using index primer 1 (one index per
sample) and a custom transposon-speciﬁc primer, 4844 (5=-AATGATACGGCGACCACCGAGATCTACACTA
GATCGCaacttcggaataggaactaagg-3= [transposon-speciﬁc sequence is in lowercase]) to enrich for trans-
poson insertion sites and allow multiplexing sequencing; the thermocycler program was 72°C for 3 min
and 98°C for 30 s, followed by 22 cycles of 98°C for 10 s, 63°C for 30 s, and 72°C for 1 min. Each library
was puriﬁed using Agencourt Ampure XP magnetic beads. Veriﬁcation and quantiﬁcation of the resulting
libraries were calculated using a Qubit 2.0 ﬂuorometer, a 2100 Bioanalyzer (Agilent Technologies), and
quantitative PCR (qPCR) (Kapa Biosciences). All libraries were pooled in equimolar amounts to a ﬁnal
concentration of 3.2 nM and submitted for sequencing on the MiSeq platform at the Queensland Centre
for Medical Genomics (Institute for Molecular Bioscience, University of Queensland). The MiSeq se-
quencer was loaded with 12 pM of pooled library with 5% PhiX spike-in and sequenced (single-end; 101
cycles) using a mixture of standard Illumina sequencing primer and Tn5-speciﬁc sequencing primer 4845
(5=-actaaggaggatattcatatggaccatggctaattcccatgtcagatgtg-3=).
All sequence data analysis and insertion site mapping were performed as previously described (30,
32). The threshold for plasmid maintenance was set to the value of the repA gene (418 RPKM), in
accordance with previous work that has demonstrated the gene is required for IncA/C plasmid replica-
tion (19).
Construction of mini-A/C plasmids. The replicon fragment was ampliﬁed with primers 7139/7140
from puriﬁed pMS6198A, the transcriptional terminator (TT) fragment gene was ampliﬁed with primers
7141/7142 from pQE30, and the cat gene was ampliﬁed with primers 7143/7144 from pKD3. The primers
were designed so that adjacent fragments had 20-bp complementary overhangs, and a multiple-cloning
site (MCS) was included between the replicon and TT fragments. All three fragments were mixed in
equimolar ratios in a PCR using Kapa HiFi with thermocycling: 95°C; 30 cycles of 98°C for 20 s, 66°C for
20 s, and 72°C for 6 min; and a ﬁnal extension of 72°C for 8 min. The product of this reaction was
electroporated into E. coli TOP10. The desired product was conﬁrmed by PCR screening and NheI
digestion of puriﬁed plasmid DNA.
The TT fragment contained two terminators, lambda t0 and rrnB t1, separated by a cat gene. The cat
gene was removed by PCR ampliﬁcation of the plasmid using primers 7145/7146, followed by NheI
digestion 37°C for 2 h and overnight ligation with T4 DNA ligase. The product was electroporated into
E. coli TOP10, and subsequent puriﬁcation, PCR screening, and NheI digestion conﬁrmed the desired
product, which was referred to as pMAC1.
The partitioning fragments were ampliﬁed using Kapa HiFi with primers 7147/7149 for pMAC2 and
7147/7148 for pMAC3. Each fragment was cloned into the MCS of pMAC1 using BamHI and HindIII
restriction sites. The resultant plasmids (pMAC2 and pMAC3) were conﬁrmed to be correct by
sequencing.
Genome sequencing, assembly, and methylome analysis. Genomic DNA from MS6198 was
sequenced on the PacBio RSII (University of Malaya) using the P4 polymerase and C2 sequencing
chemistry. The raw sequencing data were assembled de novo using the hierarchical genome assembly
process (HGAP) version 2 from the SMRT Analysis software suite (version 2.3.0; Paciﬁc Biosciences) with
default parameters. The assembled contigs were visually screened for overlapping sequences on their 5=
and 3= ends using contiguity (67). These overlapping ends were manually trimmed based on sequence
similarity, and the contigs were circularized. The circularized contigs (chromosome and plasmids) were
then polished by mapping raw sequencing reads back onto the assembled circular contigs.
The detection of methylated bases and clustering of modiﬁed sites to identify methylation-associated
motifs was performed as previously reported (68). In brief, raw reads were aligned to the complete
genome of MS6198, and interpulse duration (IPD) ratios were calculated using PacBio’s in silico kinetic
reference computational model.
Sequence analysis, annotation, and in silico typing. Visualization and annotation of plasmid
sequences were performed using PROKKA v1.11 (69) and the Artemis Genome Browser (70). Sequence
comparisons were constructed using WebACT (71) and visualized with Easyﬁg 2.1 (72) and Artemis
Comparison Tool (ACT) (73). In silico DNA manipulations and analysis were conducted and visualized in
CLC Main Workbench (version 7.0.2; Qiagen Bioinformatics) and Easyﬁg 2.1 (72). In silico E. coli multilocus
sequence typing was performed using the MLST database hosted at the University of Warwick (74).
Plasmid Inc types were determined by PCR-based replicon typing (63, 64) or in silico using PlasmidFinder
(60).
Collection of IncA/C complete sequences and analysis. Complete sequences of IncA/C plasmids
from GenBank were selected by BLASTn using the sequence of RA1 repA as a reference (90% identity
and 90% query coverage). The BLASTn hits were manually reviewed, and only published sequences
were included in our IncA/C plasmid database. Each plasmid sequence was also veriﬁed by BLASTn to
contain IncA/C replicon-typing primer binding sites (63). With the addition of pMS6198A, this database
comprised 82 IncA/C plasmid sequences (as of 9 May 2016) (see Data Set S5 in the supplemental
material). The gene annotations of pMS6198A were used as a reference to identify genes present in all
82 IncA/C plasmids, using default BLASTn v2.2.26 settings with the criteria of an expected value of 1030
and minimum coverage of 95%. The sequence of each conserved gene was extracted from each plasmid
using EMBOSS v6.5.7 (75). PMLST minimal spanning trees were built by Phyloviz using the goeBURST
algorithm (76). All alignments were constructed in MEGA 6.06 (77) using ClustalW with default settings.
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Phylogenetic trees were produced in MEGA 6.06 using maximum likelihood with default settings and
supported with 1,000 bootstraps. The presence or absence of resistance genes was determined using the
BLASTn algorithm (100% identity at 100% coverage) against the resistance gene database ARG-ANNOT
(78). IncA/C sequence analysis and metadata have been incorporated into the microreact database
(https://microreact.org/project/IncACPlasmids?ttrc&tns4&tts6) (80).
Accession number(s). The sequences for the MS6198 chromosome, pMS6198A, pMS6198B,
pMS6198C, and pMS6198D have been deposited in the NCBI GenBank database under accession
numbers CP015834 to CP015838, respectively. Raw PacBio sequence reads for MS6198 and Illumina
MiSeq reads for duplicate TraDIS runs have been deposited in the Sequence Read Archive (SRA) under
accession numbers SRX1797306, SRX1992326 (replicate 1), and SRX1992327 (replicate 2), respectively.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
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